Tandem Diabetes Care, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Tandem Diabetes Care, Inc. (TNDM) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$30.98 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-01
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $1.62M, a 93.93% decline year-over-year.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$15.27M.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$12.98M.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$4.34M.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$30.98M, a 2048.30% decline from fiscal 2016.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $1.59M, a 86.65% decline from fiscal 2015.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $11.91M.
- Tandem Diabetes Care, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$93.21M, a 186.93% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$13.65M derived: sum of 2 quarters · filed 2018-03-01 | -$26.63M derived: sum of 3 quarters · filed 2018-03-01 | -$30.98M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | -$15.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$28.25M derived: sum of 2 quarters · filed 2017-10-26 | -$32.60M 10-Q · filed 2017-10-26 | -$5.88M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-06-30 | -$12.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$17.33M 10-Q · filed 2017-07-27 | $9.39M derived: sum of 3 quarters · filed 2018-03-01 | -$2.90M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-03-31 | -$4.34M 10-Q · filed 2017-04-27 | $22.38M derived: sum of 2 quarters · filed 2018-03-01 | $10.08M derived: sum of 3 quarters · filed 2018-03-01 | -$276.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-12-31 | $26.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $14.43M derived: sum of 2 quarters · filed 2018-03-01 | $4.07M derived: sum of 3 quarters · filed 2018-03-01 | $1.59M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | -$12.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$22.65M derived: sum of 2 quarters · filed 2017-10-26 | -$25.13M 10-Q · filed 2017-10-26 | -$25.25M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | -$10.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$12.84M 10-Q · filed 2017-07-27 | -$12.96M derived: sum of 3 quarters · filed 2018-03-01 | -$15.67M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | -$2.48M 10-Q · filed 2017-04-27 | -$2.60M derived: sum of 2 quarters · filed 2018-03-01 | -$5.31M derived: sum of 3 quarters · filed 2018-03-01 | -$21.94M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$2.83M derived: sum of 2 quarters · filed 2018-03-01 | -$19.46M derived: sum of 3 quarters · filed 2018-03-01 | $11.91M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$19.34M derived: sum of 2 quarters · filed 2016-11-01 | $12.03M 10-Q · filed 2016-11-01 | $7.65M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | -$16.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $14.74M 10-Q · filed 2016-07-28 | $10.36M derived: sum of 3 quarters · filed 2017-03-08 | -$18.29M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $31.37M 10-Q · filed 2016-04-28 | $26.99M derived: sum of 2 quarters · filed 2017-03-08 | -$1.66M derived: sum of 3 quarters · filed 2017-03-08 | -$14.28M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$33.03M derived: sum of 2 quarters · filed 2017-03-08 | -$45.65M derived: sum of 3 quarters · filed 2017-03-08 | -$93.21M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | -$28.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$41.27M derived: sum of 2 quarters · filed 2015-10-29 | -$88.83M 10-Q · filed 2015-10-29 | -$88.83M 10-Q · filed 2014-11-06 | $20.01M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | -$12.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$60.18M 10-Q · filed 2015-07-30 | -$60.18M 10-Q · filed 2014-07-31 | $48.66M derived: sum of 3 quarters · filed 2016-02-24 | $34.08M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | -$47.56M 10-Q · filed 2015-04-30 | -$47.56M 10-Q · filed 2014-05-06 | $61.28M derived: sum of 2 quarters · filed 2016-02-24 | $46.69M derived: sum of 3 quarters · filed 2016-02-24 | $47.39M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $108.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $94.25M derived: sum of 2 quarters · filed 2016-02-24 | $94.95M derived: sum of 3 quarters · filed 2016-02-24 | $107.22M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | -$14.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$13.89M derived: sum of 2 quarters · filed 2014-11-06 | -$1.61M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $694.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $12.97M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $12.27M 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $8.51M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |